Cumulative D-Index Predicts the Duration of Febrile Neutropenia in AML Patients

被引：0
|
作者：
Kubo, Hiroyuki [1 ]
Imataki, Osamu [1 ]
Uchida, Shumpei [1 ]
Yokokura, Shigeyuki [1 ]
Uemura, Makiko [1 ]
Kadowaki, Norimitsu [2 ]
机构：
[1] Kagawa Univ, Kagawa, Japan
[2] Kagawa Univ, Div Hematol Rheumatol & Resp Med, Dept Intern Med, Kagawa, Japan
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5180.5180
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5180
引用
收藏
页数：4
相关论文
共 50 条
  • [31] EVALUATION OF THE COMPLICATION RATE AND COST OF TREATMENT ACCORDING TO THE MASCC INDEX IN PATIENTS WITH FEBRILE NEUTROPENIA
    Borget, I
    Bonnet, P.
    Gachot, B.
    Di Palma, M.
    Antoun, S.
    Merad, M.
    VALUE IN HEALTH, 2009, 12 (07) : A267 - A267
  • [32] Lower c-D-Index in Acute Myeloid Leukemia with Febrile Neutropenia during Chemotherapy
    Ishida, Tomoya
    Kubo, Hiroyuki
    Imataki, Osamu
    Uemura, Makiko
    Kadowaki, Norimitsu
    BLOOD, 2019, 134
  • [33] A retrospective study of D-index in acute myeloid leukemia patients undergoing induction chemotherapy
    Shibata, Yuhei
    Matsumoto, Takuro
    Nakamura, Nobuhiko
    Kitagawa, Junichi
    Morikawa, Akemi
    Kanemura, Nobuhiro
    Hara, Takeshi
    Tsurumi, Hisashi
    ANNALS OF ONCOLOGY, 2015, 26 : 94 - 94
  • [34] D-index as a marker of bloodstream infections in patients with allogeneic hematopoietic stem cell transplantation
    Vijayvargiya, Prakhar
    Abad, Cybele Lara
    Garrigos, Zerelda Esquer
    O'Horo, John C.
    Walker, Randall C.
    Hogan, William J.
    Tande, Aaron J.
    TRANSPLANT INFECTIOUS DISEASE, 2021,
  • [35] Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia
    Biron, P
    Fuhrmann, C
    Cure, H
    Viens, P
    Lefebvre, D
    Thyss, A
    Viot, M
    Soler-Michel, P
    Rollin, C
    Grès, JJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (04) : 511 - 518
  • [36] Author Correction: Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia
    Hanine El Haddad
    Anne-Marie Chaftari
    Ray Hachem
    Majd Michael
    Ying Jiang
    Ammar Yousif
    Sammy Raad
    Mary Jordan
    Patrick Chaftari
    Issam Raad
    Scientific Reports, 8
  • [37] Classical Empiric Antifungal Therapy Vs. D-Index Guided Early Therapy Using Micafungin for Persistent Febrile Neutropenia (CEDMIC trial): A Randomized Controlled Trial from Japan FN Study Group
    Kimura, Shun-Ichi
    Kanda, Yoshinobu
    Iino, Masaki
    Fukuda, Takahiro
    Sakaida, Emiko
    Oyake, Tatsuo
    Yamaguchi, Hiroki
    Fujiwara, Shin-ichiro
    Suzumiya, Junji
    Okamoto, Akinao
    Fujita, Hiroyuki
    Takamatsu, Yasushi
    Saburi, Yoshio
    Yamanouchi, Jun
    Matsumura, Itaru
    Shiratori, Souichi
    Gotoh, Moritaka
    Nakamura, Shingen
    Tamura, Kazuo
    BLOOD, 2018, 132
  • [38] The Charlson Comorbidity Index Predicts Poor Prognosis in Elderly AML Patients br
    Tiglioglu, Mesut
    Albayrak, Murat
    Tiglioglu, Pinar
    Yildiz, Abdulkerim
    Dogan, Servihan
    Afacan Ozturk, Hacer Berna
    Maral, Senem
    Saglam, Bugra
    Aras, Merih Reis
    Dilek, Imdat
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2023, 33 (01): : 1 - 6
  • [39] Cathelicidin, but not vitamin D, is associated independently with sepsis in pediatric patients with cancer and febrile neutropenia
    Garcia-Garcia, Paola E.
    Palomo-Colli, Miguel A.
    Silva-Jivaja, Karla M.
    Juarez-Villegas, Luis E.
    Vidal-Romero, Gustavo
    Sanchez-Rodriguez, Martha A.
    Castelan-Martinez, Osvaldo D.
    MOLECULAR AND CLINICAL ONCOLOGY, 2025, 22 (02)
  • [40] Pentraxin 3 predicts complicated course of febrile neutropenia in haematological patients, but the decision level depends on the underlying malignancy
    Juutilainen, Auni
    Vanska, Matti
    Pulkki, Kari
    Hamalainen, Sari
    Nousiainen, Tapio
    Jantunen, Esa
    Koivula, Irma
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 87 (05) : 441 - 447
12345